We show that treating SAF with IL-36Ra or using a therapeutic antibody that blocks IL-36R–mediated signaling inhibits viral-induced IL-36–mediated inflammatory crosstalk between SAEC and SAF in COPD. The gene discussed is IL1RL2; the disease is chronic obstructive pulmonary disease.